Abstract
Background
The purpose of this study was to determine the reliability of detecting age-related macular degeneration (AMD) during screening for diabetic retinopathy (DR).
Methods
This prospective study included 2,003 subjects with diabetes mellitus who underwent photographic screening for DR. The reliability of detecting AMD lesions was tested by interobserver and intraobserver agreement, and the sensitivity and specificity of diagnosing AMD at different grades of severity were tested using the consensus grading of a group as the reference standard.
Results
DR affected 24.7 % of the subjects. The age-standardized prevalence of early AMD was 17.9 %, and late AMD was 0.1 %. The interobserver and intraobserver agreement for grading AMD was substantial (k = 0.72 and 0.71 respectively, p < 0.001). It was equally good in those with different severities of DR. There was also no difference in sensitivity and specificity of detecting AMD in those with different levels of DR (sensitivity 62–68 % and specificity 97–98 %).
Conclusion
Intermediate- and high-risk AMD that warrant treatment with zinc and anti-oxidant supplements could be reliably detected during screening for diabetic retinopathy.
Similar content being viewed by others
References
Congdon NG, Friedman DS, Lietman T (2003) Important causes of visual impairment in the world today. JAMA 290:2057–2060
Fong DS, Aiello LP, Ferris FL III et al (2004) Diabetic retinopathy. Diabetes Care 27:2540–2553
Ong HS, Levin S, Franzco et al (2013) (J Glaucoma 2012;00:000–000). Glaucoma detection using optic disc images from the English National Screening Programme for Diabetic Retinopathy. J Glaucoma 22:496–500
Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 99:933–943
Vingerling JR, Dielemans I, Hofman A et al (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102:205–210
Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102:1450–1460
WHO Vision (2020) The right to sight. Global Initiative for the elimination of avoidable blindness. Action plan 2006–2011. Available at: http://www.who.int/blindness/causes/priority/en/index8.html
Age-Related Eye Disease Study Research group (2001) A randomized, placebo-controlled, clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 119:1417–1436
Rein DB, Saaddine JB, Wittenborn JS et al (2007) Cost-effectiveness of vitamin therapy for age-related macular degeneration. Ophthalmology 114(7):1319–1326
Schmier JK, Jones ML, Halpern MT (2006) The burden of age-related macular degeneration. Pharmacoeconomics 24(4):319–334
Karnon J, Czoski-Murray C, Smith K et al (2008) A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration. Health Technol Assess 12(27):iii–iv, ix–124
Le Tien V, Streho M, D’Athis P et al (2008) Interobserver reliability of detecting age-related macular degeneration using a nonmydriatic camera. Am J Ophthalmol 146:520–526
Seddon JM, Sharma S, Adelman RA (2006) Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 113:260–266
Kinshuck D (2008) Examining and grading retinopathy, for professionals. Available at: http://medweb.bham.ac.uk/easdec/gradingretinopathy.htm
Klein R, Davis MD, Magli YL et al (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128–1134
The Age-Related Eye Disease Study Research group (2001) The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study report number 6. Am J Ophthalmol 132:668–681
Seddon JM, Rosner B, Sperduto RD et al (2001) Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 119:1191–1199
Klein R, Cruickshanks KJ, Nash SD et al (2010) The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 128:750–758
Chen SJ, Cheng CY, Peng KL et al (2008) Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci 49:3126–3133
Voutilainen-Kaunisto RM, Terasvirta ME, Uusitupa MIJ et al (2000) Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects—a 10 year follows up on evolution, risk factors, and prognostic significance. Diabetes Care 23:1672–1678
Williams MA, Craig D, Passmore P, Silvestri G (2009) Retinal drusen: harbingers of age, safe havens for trouble. Age Ageing 38(6):648–654
Klein R (2003) Retinopathy and other ocular complications in diabetes. In: Porte D, Sherwin RS, Baron A (eds) Ellenberg & Rifkin’s diabetes mellitus, 6th edn. McGraw–Hill, New York, p 664
Bressler SB, Maguire MG, Bressler NM et al (1990) Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 108:1442–1447
Macula Photocoagulation Study Group (1997) Risk factors for choroidal neovascularisation in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 115:741–747
Klein R, Klein BE, Knudtson M et al (2006) Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113:373–380
Wu LZ, Chen YZ, Chao XY et al (1987) Aging macular degeneration in Tibetan and Han. Yan Ke Xue Bao 3:179–181
Wu LZ, Chen YZ, Liu AQ et al (1987) Aging macular degeneration in Uighur. Yan Ke Xue Bao 3:175–178
Wu ZQ (1992) Epidemiologic survey of senile macular degeneration. Zhonghua Yan Ke Za Zhi 28:246–247
Hahn P, Acquah K, Cousins SW, Lee PP, Sloan FA (2013) Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries. Retina 33:911–919
Accessed at http://diabeticeye.screening.nhs.uk/workbook-section14
Aldington S, Kohner E, Meuer S, Klein R, Sjolie A (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38:437–444
Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Barned N et al (2003) The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabet Med 20(6):467–474
Scanlon PH, Malhotra R, Greenwood RH, Aldington SJ, Foy C, Flatman M et al (2003) Comparison of two reference standards in validating two-field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthalmol 87(10):1258–1263
Conflict of interest
No conflicting relationship exists for any author.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gangwani, R., Lai, W.W., Sum, R. et al. The incidental findings of age-related macular degeneration during diabetic retinopathy screening. Graefes Arch Clin Exp Ophthalmol 252, 723–729 (2014). https://doi.org/10.1007/s00417-013-2530-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-013-2530-1